The short answer. Is Liqitomic a good franchise? It is a specialist, business-to-business Liqitomic franchise proposition built on a technology rather than a storefront. The brand sells on-site treatment of human and animal anatomical waste, developed by the UK-based decontamination group Sanondaf. It suits operators who already sell into hospitals, laboratories and veterinary networks and who are comfortable with a technical, compliance-led sale. It does not suit anyone looking for a consumer-facing retail format.
Liqitomic is a next-generation anatomical waste disposal technology developed by Sanondaf, a UK-based specialist in advanced decontamination systems operating since 2014. Instead of incineration, the system uses a chemical dissolution process that treats anatomical waste, including bone, tissue and skin, and neutralises it for standard discharge. According to VF’s brand page, a typical cycle runs for under one hour.
The model is on-site. Units are compact and portable and can be installed at the point where the waste is produced, which removes manual handling, freezing and transport from the process. The brand states that the process was validated through an 18-month project and scientific trials at a leading UK university, and that it has been proven in commercial operations.
Healthcare capacity is expanding across Asia Pacific and the Middle East and North Africa, and every hospital, teaching facility and veterinary clinic that grows adds to the volume of regulated waste it has to manage. A treatment that works at the point of origin appeals to operators who are weighing the energy demand and logistics of centralised incineration. That is a market-fit observation drawn from the concept’s design, not a forecast of demand in any named country.
A technology-led franchise stands or falls on the partner’s ability to sell, install and support the equipment. These are the questions a prospective partner should answer before approaching the brand:
| Operator background | Why it fits | What to confirm |
|---|---|---|
| Medical waste and environmental services | Existing customer base and regulatory knowledge | How on-site treatment sits alongside current contracts |
| Medical equipment distributors | Installed relationships with hospital buyers and service engineers | Capacity to add a compliance-led product line |
| Veterinary and laboratory suppliers | Direct reach to clinics and research facilities | Fit with the animal-waste application |
| Industrial investors with a healthcare focus | Capital discipline and ability to hire technical teams | Local approvals and service staffing plan |
Because the units are compact and portable, the site question is about the customer’s facility rather than a retail lease. A partner would need to confirm, for each installation, where the unit can sit within a hospital, laboratory or veterinary building, how waste is brought to it, and how treated output meets the discharge standards that apply locally. The brand’s own materials describe neutralisation for standard discharge, so the local authority’s requirements are the point to check early. Training for the customer’s staff and a clear service routine are part of what a partner would be expected to provide.
VF’s brand page does not publish the countries currently available, so this article does not present any market as open. Territory availability, structure and terms are discussed directly with VF. Operators researching the category can read how master franchise, area development and joint venture structures compare, and how franchisors qualify a master franchisee before awarding rights.
Liqitomic is a product of Sanondaf. The group’s other concept is covered in Sanondaf franchise: inside the B2B decontamination model and Is Sanondaf a good franchise, and an earlier article looked at Liqitomic territory rights across Asia Pacific and MENA. For regional market context, see the Saudi Arabia franchise opportunities guide and the master franchise agreements investor guide for Saudi Arabia. A structured due diligence process for master franchise partners is a sensible step before any conversation about rights.
It is a technology-based franchise in which a partner represents on-site anatomical waste treatment equipment in a defined market. The units serve hospitals, laboratories, universities and veterinary facilities.
Liqitomic uses chemical dissolution rather than heat. The brand says this removes the need for manual handling, freezing and transport, and lowers the carbon footprint compared with traditional methods.
VF discusses the entry investment directly with qualified operators, so no figure is quoted here. Contact VF for the current level and what it covers.
Availability is not published on the brand page. VF discusses territory directly with qualified operators.
It suits established businesses in medical waste, environmental services, equipment supply or healthcare logistics that want to add a specialist technology to an existing customer base.
For the brand’s own description of the technology, visit the official Liqitomic website.
Email: info@vffranchiseconsulting.com | Hotline: +84 90 306 54 58
Author: Sean T. Ngo, CEO and Co-founder of VF Franchise Consulting.
